Gene transfer as a future therapy for rheumatoid arthritis (Q35164793)

6 August 2017

1 reference

title

Gene transfer as a future therapy for rheumatoid arthritis (English)

1 reference

6 August 2017

0 references

1

Ulf Müller-Ladner

1 reference

6 August 2017

Thomas Pap

2

1 reference

6 August 2017

Renate E Gay

series ordinal

3

1 reference

6 August 2017

Steffen Gay

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

587-598

1 reference

Gene therapy in rheumatoid arthritis: how to target joint destruction?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Myoblast-mediated gene transfer to the joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

C3-Tat/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Transcriptional activation by tetracyclines in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Adenoviral-mediated gene transfer to rabbit synovium in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Recombinant adeno-associated virus for muscle directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Persistent, therapeutically relevant levels of human granulocyte colony-stimulating factor in mice after systemic delivery of adeno-associated virus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

In vivo gene delivery to synovium by lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Efficient lipid-mediated gene transfer to articular chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Molecular lysis of synovial lining cells by in vivo herpes simplex virus-thymidine kinase gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Non-viral gene delivery in skeletal muscle: a protein factory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Progress and prospects: naked DNA gene transfer and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Anticytokine gene therapy of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Synthetic hammerhead ribozymes as tools in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Ribozyme-based gene cleavage approach to chronic arthritis associated with human T cell leukemia virus type I: induction of apoptosis in synoviocytes by ablation of HTLV-I tax protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Chemically modified ribozyme targeting TNF-alpha mRNA regulates TNF-alpha and IL-6 synthesis in synovial fibroblasts of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Gene silencing by adenovirus-delivered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21(Cip1) gene into the joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Successful gene therapy via intraarticular injection of adenovirus vector containing CTLA4IgG in a murine model of type II collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Gene therapy in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Comparison of the Suppressive Effects of Antisense Oligonucleotides and siRNAs Directed Against the Same Targets in Mammalian Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.587

21 January 2018

Identifiers

DOI

10.1517/14712598.3.4.587

1 reference

6 August 2017

1 reference